Medpace Holdings (XTER:01P) 14-Day RSI: N/A (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:01P Medpace Holdings Inc XTER:01P
96 GF Score
Price €524.00
GF Value €462.90
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medpace Holdings 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2026-08-29), Medpace Holdings's 14-Day RSI is N/A.

The industry rank for Medpace Holdings's 14-Day RSI or its related term are showing as below:

XTER:01P's 14-Day RSI is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 52.17
* Ranked among companies with meaningful 14-Day RSI only.

Medpace Holdings  (XTER:01P) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

Medpace Holdings 14-Day RSI Related Terms

XTER:01P vs : 14-Day RSI Comparison

For the Diagnostics & Research subindustry, Medpace Holdings's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medpace Holdings 14-Day RSI vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's 14-Day RSI falls into.


XTER:01P
96GF Score
Medpace Holdings Inc XTER:01P
14-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medpace Holdings  (XTER:01P) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Medpace Holdings (XTER:01P) Overvalued in 2026?

Based on GuruFocus' analysis, Medpace Holdings stock appears to be overvalued. The current stock price of €524.00 is trading 13.2% above its estimated GF Value™ of €462.90. GuruFocus considers Medpace Holdings to be Modestly Overvalued.

Key valuation signals for XTER:01P:

  • 14-Day RSI: N/A
  • GF Value™: €462.90 vs. price of €524.00 (13.2% above fair value)
  • GF Score™: 96/100 with 2 warning signs

No single metric tells the full story. See the XTER:01P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medpace Holdings Business Description

Comparable Companies
Address 5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
96GF Score

Get the complete analysis for XTER:01P

14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€524.00
Price
€462.90
GF Value